|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.990 CNY | +0.81% |
|
-3.11% | -2.54% |
| 07-29 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 24.88B 3.69B 3.19B 2.98B 2.73B 5.14B 351B 5.22B 34.94B 13.72B 176B 13.85B 13.54B 581B | P/E 2026 * |
10.8x | P/E 2027 * | 10x |
|---|---|---|---|---|---|
| Enterprise Value | 20.56B 3.05B 2.64B 2.46B 2.26B 4.25B 290B 4.31B 28.88B 11.33B 145B 11.44B 11.19B 480B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.19% | Yield 2027 * | 4.46% |
| 1 day | +0.81% | ||
| 1 week | -3.11% | ||
| Current month | -3.11% | ||
| 1 month | -0.40% | ||
| 3 months | -1.19% | ||
| 6 months | -4.41% | ||
| Current year | -2.54% |
| 1 week | 4.87 |  | 5.2 |
| 1 month | 4.87 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 14/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 04/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 30/06/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.81% | -3.11% | -6.73% | -8.23% | 3.69B | |
| -0.21% | +1.56% | +30.06% | +103.30% | 101B | |
| -0.53% | +2.77% | +50.18% | +157.63% | 55.37B | |
| -0.33% | +1.36% | +4.20% | +277.22% | 24.21B | |
| +1.64% | -0.95% | -12.47% | -14.05% | 8.29B | |
| +4.21% | -0.41% | -31.74% | -26.33% | 7.53B | |
| -0.82% | -2.42% | -10.17% | -20.93% | 6.75B | |
| +0.14% | +0.19% | +19.28% | +12.93% | 6.19B | |
| -1.85% | -4.36% | -2.55% | +21.15% | 5.07B | |
| +1.14% | -1.73% | +9.64% | +17.04% | 3.68B | |
| Average | +0.42% | -0.49% | +4.97% | +51.97% | 22.22B | |
| Weighted average by Cap. | -0.09% | +1.33% | +25.36% | +115.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.16B 21.76B 20.32B 18.64B 35.07B 2,395B 35.62B 238B 93.59B 1,200B 94.48B 92.41B 3,968B | 178B 26.43B 22.86B 21.35B 19.59B 36.84B 2,516B 37.43B 251B 98.32B 1,261B 99.26B 97.08B 4,168B |
| Net income | 2.33B 345M 299M 279M 256M 481M 32.84B 489M 3.27B 1.28B 16.46B 1.3B 1.27B 54.42B | 2.52B 373M 323M 301M 276M 520M 35.5B 528M 3.53B 1.39B 17.79B 1.4B 1.37B 58.82B |
| Net Debt | -4.32B -640M -554M -517M -474M -892M -60.93B -907M -6.07B -2.38B -30.54B -2.4B -2.35B -101B | -5.04B -747M -646M -604M -554M -1.04B -71.12B -1.06B -7.08B -2.78B -35.65B -2.81B -2.74B -118B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | CN¥4.990 | +0.81% | 32,870,562 |
| 06/08/26 | CN¥4.950 | +0.81% | 39,173,156 |
| 05/08/26 | CN¥4.910 | -2.96% | 61,506,086 |
| 04/08/26 | CN¥5.060 | -1.75% | 34,518,740 |
| 03/08/26 | CN¥5.150 | 0.00% | 28,083,420 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
